Would you like to receive important updates about Endo International PLC like earnings dates and more?
ENDP Stock Price Today $7.72
Year To Date
The Year To Date (YTD) return is -55.81%.
52 Week Low
The 52 Week Low stock price is 7.40 set on Tue, Oct 17, 2017 which is 6 days ago.
The current price per share is 4.32% above the 52 week low.
52 Week High
The 52 Week High stock price is $21.87 set on Tue, Oct 25, 2016 which is 363 days ago.
The current price per share is -64.70% below the 52 week high.
All Time High
The All Time High stock price is $96.58 set on Thu, Apr 16, 2015 which is 921 days ago.
The current price per share is -92.01% below the all time high.
Endo Stock Charts
5 Year Stock Chart
The Endo 5 year stock chart shows the historical prices over the previous 60 months.
1 Year Stock Chart
The Endo 1 year stock chart shows the historical prices over the previous 12 months.
50 Day Moving Average
The 50 Day Moving Average is at $10.15 which is 23.94% above the stock price of $7.72.
200 Day Moving Average
The 200 Day Moving Average is at 12.21 which is 36.77% above the stock price of $7.72.
Because both the 50 DMA and 200 DMA are above the current stock price, this can be considered a bearish technical indicator.
Since the stock price is very far from both moving averages, a price retracement towards the moving averages should not be unexpected.
ENDP Company Profile
Endo International PLC is a Health Care stock that trades on the NASDAQ and has a market capitalization of $1.72 Billion.
Endo International plc is a generics and specialty branded pharmaceutical company. The Company operates through three segments: U.S. Generic Pharmaceuticals, U.S. Branded Pharmaceuticals and International Pharmaceuticals. It has a portfolio of branded pharmaceuticals offered by its U.S. Branded Pharmaceuticals segment that includes brand names, such as Lidoderm, OPANA ER, Voltaren Gel, Percocet, Fortesta Gel, Testim, TESTOPEL, Aveed, Supprelin LA and XIAFLEX. Its non-branded U.S. Generic Pharmaceuticals portfolio consists of products, such as tablets, capsules, powders, injectables, liquids, nasal sprays, ophthalmics and patches. The Company's generics portfolio has a range of dosage forms and delivery systems. The International Pharmaceuticals segment includes various specialty pharmaceutical products for the Canadian, Latin American and world markets.
Below are several other Biotech & Pharma stocks include AbbVie Inc (ABBV), Allergan PLC (AGN), Alexion Pharmaceuticals Inc (ALXN), Amgen Inc (AMGN), Biogen Inc (BIIB), BioMarin Pharmaceutical Inc (BMRN), Bristol-Myers Squibb Co (BMY), Celgene Corp (CELG), Endo International PLC (ENDP), Gilead Sciences Inc (GILD), .
Earnings Per Share
The EPS is -$23 and the P/E Ratio is 0.
A negative Earnings Per Share (EPS) means that this company is losing money and not profitable at this time.
The Earnings Release Date was Tue, Aug 8, 2017.
Since this earnings release 76 days ago, the stock price is down by -17.08%.
Many investors know the importance of a companies earnings report. Also, the market reaction to the earnings release can be even more important and can help in making a prediction of a future price forecast of the shares.
A significant post earnings announcement percentage move can continue or reverse an existing trend for several days or weeks after the earnings date.
The next Earnings Release Date is, after the market close, on Thu, Nov 9, 2017, which is in 17 days.
ENDP currently does not pay a dividend.
Investors should understand the dividend history of a company. Dividend history will show the dividend payments disbursed to investors over the years.